You are here

Article Text

Article menu
Download PDFPDF
Editorial
Dietary metabolism, gut microbiota and acute heart failure

http://dx.doi.org/10.1136/heartjnl-2016-309268

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors WHWT drafted the editorial and SLH critically reviewed and edited the final version.

    • Funding Supported by grants from the National Institutes of Health and the Office of Dietary Supplements (R01HL103866, P20HL113452 and R01DK10600).

    • Competing interests SLH are named as coinventor on pending patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. SLH reports having been paid as a consultant for the following companies: Esperion and P&G. SLH reports receiving research funds from Abbott, P&G, Pfizer, Roche Diagnostics and Takeda. SLH reports having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from the following companies: Cleveland Heart Lab, Siemens, Esperion and Frantz Biomarkers LLC.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles